From: Application of advanced biomaterials in photothermal therapy for malignant bone tumors
Biomaterial | Combination therapeutic strategies | Composition | Type of photosensitizers | Therapeutic agents for bone tumor | Functions | Ref. |
---|---|---|---|---|---|---|
NPs | chemotherapy | Fe3O4 NPs/ZOL | ICG | ZOL-modified PLGA | Magnetic targeting/Bone targeting/Controlled drug release | [22] |
chemotherapy | GNPs/mesoporous silica/MOF/ BYL719/ cisplatin | ICG | BYL719/ cisplatin | Tumor targeting/Photoacoustic imaging | [55] | |
PDT | AgBiS2 NPs | AgBiS2 NP | ROS | CT imaging/Antibacterial | [192] | |
immunotherapy | GNR/PEI/cGAMP/anti-PD-1 | GNR | cGAMP/anti-PD-1 | Reverse immune tolerance | [216] | |
BC scaffolds | chemotherapy | TCP scaffold/TiN microparticles/DOX | TiN microparticle | DOX | Multiple therapeutic platform | [129] |
PDT | Inorganic CaSiO3 bioceramic/Fe | Fe | ROS | Mechanical support/ Osteogenesis | [133] | |
immunotherapy | Biodegradable bioglass scaffold/Nb2C MXene NS/Mesoporous silica/R837 | Nb2C@Si NS | R837/anti-PD-1 | Robust immune memory | [215] | |
Hydrogels | chemotherapy | Hybrid methylcellulose hydrogel/Curcumin-loaded microspheres | IR820 | Curcumin | Controlled drug release/Osteogenesis | [145] |
chemotherapy | PDA/ n-HA/ cisplatin/oxidized sodium alginate/CS | PDA | Cisplatin | Sustained drug release/Osteogenesis | [148] | |
PDT | PNT-gel | ICG | ROS | Controlled release ICG by gel-sol transition | [237] | |
antibacterial therapy | GelMA hydrogel/MXene NSs/SP/PDA | PDA and MXene | TOB | Osteogenesis | [238] | |
Polymers | bone regeneration | CPC/Co-TCPP MOF/GO | GO | Co ions | Osteogenesis | [159] |
antibacterial therapy | PEEK/Graphene NSs/Stearyltrimethylammonium chloride-hydroxyapatite | Graphene NS | Stearyltrimethylammonium chloride-hydroxyapatite | Antibacterial/Osteogenesis/Multiple therapeutic platforms | [162] | |
bone regeneration | PCL/SrCuSi4O10 NS | SrCuSi4O10 NSs | Sr, Cu, and Si ions | Controlled and sustained ions release/Osteogenesis | [167] |